Icarisid Ⅱ modulates mitochondrial dynamics for anti-HBV activity
ICS Ⅱ exhibits significant anti-HBV potential through its regulation of mitochondrial dynamics and ROS production.
Authors
- Di Xiao (ORCID: https://orcid.org/0000-0003-2419-7840)
- Zhengyun Liu
- Juan Wen (ORCID: https://orcid.org/0000-0001-9832-2056)
- Qihai Gong (ORCID: https://orcid.org/0000-0002-8967-337X)
- Guo Qing Luo (ORCID: https://orcid.org/0000-0002-5457-5921)
- Huan Wang (ORCID: https://orcid.org/0000-0002-4057-1145)
- Yu Wan (ORCID: https://orcid.org/0000-0002-0178-2310)
- Haiyan Yang
Institutions
- Zunyi Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.3389/fphar.2025.1544714
- Citations
- 2
- Primary Topic
- Toxoplasma gondii Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.10
Funders
- National Natural Science Foundation of China
- Fudan University